Pacira BioSciences (PCRX) Return on Capital Employed Growth (3y) (2014 - 2026)
Pacira BioSciences (PCRX) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1,301.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 331.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -667.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 480.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -254.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1,342.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1,902.00 |
| 10 | Pacira BioSciences | 1.05 Bn | 846.97 Mn | 140.96 Mn | -49.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.00 |
| Dec 31, 2025 | -219.00 |
| Sep 30, 2025 | -145.00 |
| Jun 30, 2025 | -1,337.00 |
| Mar 31, 2025 | -1,197.00 |
| Dec 31, 2024 | -1,350.00 |
| Sep 30, 2024 | -1,445.00 |
| Jun 30, 2024 | -235.00 |
| Mar 31, 2024 | 236.00 |
| Dec 31, 2023 | 135.00 |
| Sep 30, 2023 | 3.00 |
| Jun 30, 2023 | 156.00 |
| Mar 31, 2023 | -92.00 |
| Dec 31, 2022 | 237.00 |
| Sep 30, 2022 | 163.00 |
| Jun 30, 2022 | 164.00 |
| Mar 31, 2022 | 153.00 |
| Dec 31, 2021 | 493.00 |
| Sep 30, 2021 | 734.00 |
| Jun 30, 2021 | 764.00 |